Delcath Systems, Inc.
$10.88
▲
0.94%
2026-04-21 06:23:00
www.delcath.com
NCM: DCTH
Explore Delcath Systems, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$377.34 M
Current Price
$10.88
52W High / Low
$18.23 / $8.12
Stock P/E
139.76
Book Value
$3.21
Dividend Yield
—
ROCE
0.59%
ROE
3%
Face Value
—
EPS
$0.07
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
156
Beta
0.43
Debt / Equity
0.84
Current Ratio
10.92
Quick Ratio
9.98
Forward P/E
-51.22
Price / Sales
4.09
Enterprise Value
$258.75 M
EV / EBITDA
288.14
EV / Revenue
3.04
Rating
Strong Buy
Target Price
$21.33
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Tactile Systems Technology, Inc. | $25.52 | 30.42 | $580.59 M | — | 12.57% | 8.77% | $37.77 / $8.61 | $9.76 |
| 2. | Spectral AI, Inc. | $1.89 | — | $60.15 M | — | -1104.36% | 116.67% | $3.21 / $1.13 | $-0.19 |
| 3. | WORK Medical Technology Group LTD | $1.2 | — | $1.6 M | — | -4.23% | -6.45% | $10,800 / $1.05 | $17.7 |
| 4. | Profound Medical Corp. | $7.15 | — | $331 M | — | -57.78% | -67.11% | $12.4 / $5.23 | $1.83 |
| 5. | DexCom, Inc. | $63.4 | 30.77 | $24.57 B | — | 21.72% | 34.5% | $89.98 / $54.11 | $7.14 |
| 6. | Co-Diagnostics, Inc. | $1.67 | — | $6.02 M | — | -147.54% | -1.26% | $46.5 / $1.35 | $9.85 |
| 7. | Orthofix Medical Inc. | $12.65 | — | $507.83 M | — | -12.14% | -19.34% | $16.99 / $10.24 | $11.3 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 20.73 M | 20.56 M | 24.16 M | 19.78 M | 15.1 M | — |
| Operating Profit | -2.18 M | -0.39 M | 2.59 M | 0.64 M | 3.04 M | — |
| Net Profit | -1.9 M | 0.83 M | 2.7 M | 1.07 M | -3.4 M | — |
| EPS in Rs | -0.06 | 0.02 | 0.08 | 0.03 | -0.1 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 85.23 M | 37.2 M | 2.06 M | 2.72 M |
| Operating Profit | 0.66 M | -12.41 M | -38.18 M | -33.85 M |
| Net Profit | 2.7 M | -26.39 M | -47.68 M | -36.51 M |
| EPS in Rs | 0.08 | -0.77 | -1.38 | -1.06 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 123.63 M | 76.59 M | 38.61 M | 17.86 M |
| Total Liabilities | 12.41 M | 7.84 M | 22.84 M | 23.72 M |
| Equity | 111.22 M | 68.75 M | 15.78 M | -5.86 M |
| Current Assets | 119.53 M | 73.76 M | 37.16 M | 16.16 M |
| Current Liabilities | 10.95 M | 6.14 M | 16.45 M | 14.73 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 22.52 M | -18.68 M | -31.25 M | -24.95 M |
| Investing CF | -26.59 M | -0.98 M | -19.71 M | -0.21 M |
| Financing CF | 15.05 M | 39.41 M | 51.78 M | 10.14 M |
| Free CF | 20.97 M | -19.24 M | -31.31 M | -25.16 M |
| Capex | -1.55 M | -0.56 M | -0.06 M | -0.21 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 1701.69% | -24.05% | — | — |
| Earnings Growth % | 44.66% | -30.6% | — | — |
| Profit Margin % | -70.92% | -2308.86% | -1342.7% | — |
| Operating Margin % | -33.36% | -1849.01% | -1245.05% | — |
| Gross Margin % | 83.37% | 69.25% | 74.77% | — |
| EBITDA Margin % | -32.74% | -1829.69% | -1239.1% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.